| Abstrakt: |
The article discusses the development of novel drug delivery systems, particularly focusing on nanocarriers, to address the limitations of conventional drug delivery systems in treating diseases like cancer. These systems aim to enhance drug permeation to target cells, improve patient compliance and efficacy, and reduce undesired side effects. Nanocarriers offer advantages such as targeted and controlled drug delivery, low toxicity, high bioavailability, and improved therapeutic efficiency. The research emphasizes the importance of understanding drug release mechanisms and toxicity to develop safe and efficient drug delivery systems, with potential applications in challenging diseases like cancer and cardiovascular diseases. [Extracted from the article] |
